Live Feeds
● LIVE Updated 1h ago · 6 sources tracked

The $15bn ‘viral’ AI start-up changing how American doctors treat patients

A viral artificial intelligence start-up valued at $15 billion is reshaping how American doctors treat patients. A first-of-its-kind large-scale study from Harvard Medical School documents an explosion of artificial intelligence adoption by physicians in medicine. Meanwhile, a recent paper in JAMA regarding OpenEvidence leaves open questions about clinical tools. Healthcare systems face ongoing challenges regarding trust, deployment, and practical implementation as clinicians increasingly integrate these systems into daily practice.

🎙️

Listen to Live Briefing

Real-time synthesized voice briefing · Live Feeds Desk

⏱ ~2 min
Speed:
RSS Source map (6)
⚡ Key Developments & Real-Time Context
Text size:
  • ✓ A viral artificial intelligence start-up is valued at $15 billion and is changing how American doctors treat patients.
  • ✓ A large-scale study documents the explosion of artificial intelligence adoption by physicians in medicine.
🛡️ Source Corroboration: 6 independent reporting domains (90% confidence) ⏱ Read time: ~2 min

What changed

A large-scale study from Harvard Medical School revealed a massive adoption of artificial intelligence tools by practicing physicians.

Live updates

  1. AI Start-Up Valued at $15bn Changes American Medical Care

    A viral artificial intelligence start-up valued at $15 billion is reshaping how American doctors treat patients. A first-of-its-kind large-scale study from Harvard Medical School documents an explosion of artificial intelligence adoption by physicians in medicine. Meanwhile, a recent paper in JAMA regarding OpenEvidence leaves open questions about clinical tools. Healthcare systems face ongoing challenges regarding trust, deployment, and practical implementation as clinicians increasingly integrate these systems into daily practice.

    Why it matters

    The rapid expansion of artificial intelligence in healthcare highlights a shift in clinical workflows. As evaluations from academic institutions emerge, the medical community examines how these platforms perform under real-world conditions. Questions surrounding clinical validation and adoption rates remain central to the ongoing integration of technology in patient care.

    What is confirmed

    • A viral artificial intelligence start-up is valued at $15 billion and is changing how American doctors treat patients.
    • A large-scale study documents the explosion of artificial intelligence adoption by physicians in medicine.

    Still unconfirmed

    • Four dimensions of trust govern clinical artificial intelligence deployment according to industry literature.

    What to watch next

    • Further empirical studies examining the long-term clinical outcomes of artificial intelligence use in patient care.
    • Additional peer-reviewed responses to the OpenEvidence JAMA paper.
    Sources used for this update (6)
    1. Financial Times — The $15bn ‘viral’ AI start-up changing how American doctors treat patients
    2. Harvard Medical School — First Large-Scale Study Shows How Doctors Use AI in Medicine
    3. STAT — OpenEvidence’s JAMA paper leaves open questions
    4. Wolters Kluwer — Four dimensions of trust in clinical AI
    5. Nanyang Technological University - NTU Singapore — Building Trust in AI: A Clinician's Journey from Development to Deployment
    6. Yahoo — Harvard study shows explosion of AI adoption by physicians
    confidence 90%
📊

Community Sentiment: How do you assess this situation?

Voice your perspective · Real-time aggregated sentiment from the Live Feeds community